Eiger BioPharmaceuticals (EIGR) Q4 2023 Earnings

20MarExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-7.5
-5.11
-2.71
-0.32

Details

Expected EPS
-7.5
Actual EPS
N/A
Surprise EPS
7.5
Surprise Percent
+100%

Description

Eiger BioPharmaceuticals (EIGR) will report earnings of for Q4 2023 on March 20, 2024.

0 Comments

Share your thoughts